Durability and Predicting Risks of Valve-in-Valve TAVR
Presenter
Suzanne J. Baron, M.D., FSCAI, Massachusetts General Hospital, Winchester, MA
Suzanne J. Baron, M.D., FSCAI, Massachusetts General Hospital, Winchester, MA
Learning Objectives:
- Assess whether published valve-in-valve data is strong enough to reassure patients with longer life expectancy that a VIV is a viable, lasting option in their future
- Model how to perform and when to use bioprosthetic valve fracture, using a case-based example
- Review the complications of ViV TAVR and how they can be predicted at time of first valve selection
Keywords: Structural Heart Disease (SHD) and TAVI/TAVR/Aortic Valve